SARS-CoV-2 transmission: time to rethink public health strategy
- PMID: 35298902
- PMCID: PMC8920515
- DOI: 10.1016/S1473-3099(22)00137-2
SARS-CoV-2 transmission: time to rethink public health strategy
Conflict of interest statement
HD reports personal fees from Merck Sharp & Dohme, Adcock Ingram, and conference attendance sponsorship from Merck Sharp & Dohme and Pfizer. AP declares no competing interests.
Comment on
-
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X. Epub 2022 Mar 14. Lancet Infect Dis. 2022. PMID: 35298900 Free PMC article.
References
-
- WHO Coronavirus disease (COVID-19): how is it transmitted? Dec 23, 2021. https://www.who.int/news-room/questions-and-answers/item/coronavirus-dis...
-
- WHO Transmission of SARS-CoV-2: implications for infection prevention precautions. July 9, 2020. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-c...
-
- WHO Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) February, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
